Breast |
-
Meta-analysis shows decrease in cancer risk with high folate status -
Majority of case-control studies show reduction in risk (30% to 35%) at the highest dietary intake of folate -
Might increase risk postmenopausal (statistically non-significant) -
A non-significant trend for increase in breast cancer mortality when fortified with 5 mg/d
|
Colorectal |
|
Pancreatic |
|
Ovarian |
|
Bladder |
|
Carcinoma of head and neck |
|
Stomach |
|
Esophageal and gastric |
|
Non-Hodgkin lymphoma |
|
Cervical |
|